A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

NCT00348673 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: UK-453,061
DRUG: UK-453,061

Sponsor

Pfizer

Collaborators

[object Object]